Skip to content

Effects of administrating of test foods for 8 weeks on skin condition in subjects

Effects of administrating of test foods for 8 weeks on skin condition in subjects - Effects of administrating of test foods on skin condition in subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028510
Enrollment
45
Registered
2017-08-08
Start date
2017-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Intake of placebo foods(once a day for 8 weeks) Intake of foods containing turmeric extract(once a day for 8 weeks) Intake of foods containing turmeric extract and curcumin (once a day for 8 weeks)

Sponsors

House Wellness Foods Corporation Research and Development Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy male and female aged 20 to 60 years old 2)Those whose skin photo type corresponds to Type II or III of Fitzpatrick 3)Those who have erythema on the back skin after UV irradiation 4)Those who show written consent from participating in trial 5)Those who can visit the institution in scheduled date 6)Those who agreed in writing after fully understanding the purpose and contents of this trial

Exclusion criteria

Exclusion criteria: Those who 1)have been diagnosed with photosensitivity 2)taking drugs that affect the light sensitivity of the skin 3)taking drugs, quasi-drugs, health foods, supplements that emphasizes or promotes efficacy related to the effectiveness examined in this study or joint pain improvement 4)were judged to have a skin disease of the evaluation site by the doctor 5)are using drugs or quasi-drugs that may affect the results of the trial 6)already regularly use cosmetics, foods or supplements that may affect the results of the trial 7)drinks much alcohol, or are heavy smokers 8)have risk of allergies to drugs and foods 9)are hospitalized in dermatology department 10)have factors that may affect the results of the trial on the evaluation site 11)have subjective symptoms of advanced anemia 12)receiving medical treatment at a medical institution for treatment or prevention of diseases, or judged to be in a condition requiring treatment 13)have past or current medical history 14)have received skin care treatment or massage for the evaluation site within the past 4 weeks or are scheduled to receive during the trial period 15)have been exposed to UV beyond daily living such as long-term work outdoors, exercise, sea bathing, tanning salon, etc. during the past 2 months, or planned during the trial period 16)have irregular or disturbed life rhythms such as night shifts and shift work 17)are participating in other trial, have participated in the past 4 weeks or plan to participate in other trial during scheduled period in this trial. 18)are difficult to maintain lifestyle during the trial period 19)are lactating at the time of consent acquisition, pregnant or may be pregnant, or wish to be pregnant during the trial period 20)are difficult to menstruation 21)are difficult to fill in the subject diary 22)are judged inappropriate for participating in the trial by the doctor or investigator of this trial

Design outcomes

Primary

MeasureTime frame
water content of the stratum corneum(face) transepidermal water loss(face) minimal erythema dose of ultraviolet irradiated area(back) at 0,4,and 8-week ingestion period

Secondary

MeasureTime frame
color difference(face) elasticity(face) water content of the stratum corneum of ultraviolet irradiated area(back) transepidermal water loss of ultraviolet irradiated area(back) questionnaire(Subjective symptoms of skin condition) questionnaire(Subjective symptoms of body condition) questionnaire(Subjective symptoms of mood condition) at 0,4,and 8-week ingestion period

Countries

Japan

Contacts

Public ContactTatsuya Ohara

House Wellness Foods Corporation Research and Development Institute

Ohara_Tatsuya@house-wf.co.jp072-778-1127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026